An siRNA targeting PD-L1 (siPD-L1) encapsulated in poly(lactic-co-glycolic acid) (PLGA) NP was recently used in a humanized mouse model of PC, effectively suppressing PD-L1 expression and resulting in a significant reduction in tumor progression (Jung et al., 2021). The gene discussed is CD274; the disease is pachyonychia congenita.